Similar articles

• Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?

  Ramsey-Goldman R. Ramsey-Goldman R. Nat Clin Pract Rheumatol. 2005 Dec;1(2):72-3. doi: 10.1038/ncprheum0045. Nat Clin Pract Rheumatol. 2005. PMID: 16932632 Clinical Trial. No abstract available.
• Cyclic hormonetherapy. A report on 305 cases.

  Ramont CB. Ramont CB. Geriatrics. 1966 Nov;21(11):212-5. Geriatrics. 1966. PMID: 4288699 No abstract available.
• [The urocytogram in the menopause].

  Minucci D, Gentile D, Pelusi G, Ambrosini A. Minucci D, et al. Riv Ital Ginecol. 1968 Nov;52(11):695-704. Riv Ital Ginecol. 1968. PMID: 4304075 Italian. No abstract available.
• Vascular and metabolic effects of sex steroids: new insights into clinical trials.

  Wierman ME, Kohrt WM. Wierman ME, et al. Reprod Sci. 2007 May;14(4):300-14. doi: 10.1177/1933719107303673. Reprod Sci. 2007. PMID: 17644802 Review.
• Quantitative assessment of bone mineral density during estrogen replacement therapy.

  Thijssen JH, Druckmann R. Thijssen JH, et al. Gynecol Endocrinol. 1999 Dec;13 Suppl 6:29-34. Gynecol Endocrinol. 1999. PMID: 10862266 Review. No abstract available.